Will US Physical Therapy stock go up?

According to Danelfin AI, US Physical Therapy has today an AI Score of 3/10 (Sell rating), because its probability of beating the market in 3 months (46.14%) is -4.67% vs. the average probability (50.82%) of all US-listed stocks.

What is the target price for US Physical Therapy stock?

The US Physical Therapy target price is $97.14 (1Y), according to the average price target offered by analysts.

Is it a good time to buy, sell, or hold US Physical Therapy stock right now?

US Physical Therapy has today a Sell rating (AI Score 3/10), according to Danelfin AI. Its probability of beating the market in 3 months (46.14%) is -4.67% vs. the average probability (50.82%) of all US-listed stocks, based on our AI-powered analysis. You can find more details on whether US Physical Therapy stock is a good buy .

Is US Physical Therapy undervalued right now?

Based on analysts, the average price target upside for US Physical Therapy is +36.19% (1Y). According to Danelfin AI, US Physical Therapy has today an AI Score of 3/10 (Sell Rating).

What was the price range of US Physical Therapy stock over the past 12 months?

The US Physical Therapy stock price range over the past 12 months has been $59 - $93.16.

What is going on with US Physical Therapy stock in the last 3 months?

The US Physical Therapy stock performance in the last quarter has been -4.84%.

Does US Physical Therapy offer dividend payments?

Yes, US Physical Therapy stock dividend yield is 2.55%.

What is the current market capitalization of US Physical Therapy?

US Physical Therapy's market cap is $1.09B, as of 2026-07-02 08:00.

When is the next USPH earnings report date?

USPH will publish its next earnings report on 2026-05-06.

US Physical Therapy Inc (USPH) AI Stock Analysis

Advanced Chart

Custom range

Jul 3, 2025

→

Jul 3, 2026

Custom range

Jul 3, 2025

→

Jul 3, 2026

USPH AI-Powered Stock Analysis

AI Score Explanation

AI Score

Sell

Fundamental
Technical
Sentiment
Low Risk

According to Danelfin’s proprietary AI model, US Physical Therapy Inc today receives an AI Score of 3/10, which translates to a Sell rating. The stock has a 47% probability of outperforming the market in the next 3 months, which is 4% lower than the average probability of any stock (51%). Among the top positive contributors, Alpha 1Y (risk-adjusted return over the past year) adds +0.45% to the probability, while Maximum Volatility contributes +0.33% and Earnings Countdown adds +0.30%. On the negative side, the Chart Pattern (252d) detracts -0.84%, Sentiment Impact (Long Tail) reduces -0.78%, and Distance from KAMA (20d) subtracts -0.68%, among other detractors. Notable data points include Institutional Ownership in the top 10% at 105.83%, which positively influences the probability, while Tangible Shareholders' Equity is in the bottom 20% at -426.26, a negative factor. The Fear & Greed Index is at 31 (fear territory), and Short Float (%) is in the top 30% at 7.42%, both weighing on the outlook. Overall, the stock faces more headwinds than tailwinds, with technical and sentiment signals dragging down its probability, resulting in the Sell rating.

AI Score Explanation

Generating AI Score explanation

We're getting the explanation ready so you can easily understand what's behind the AI Score. This may take a few seconds.

Size & Liquidity+0.24%
Company size and trading liquidity
Growth+0.23%
Expected pace of revenue and earnings expansion

Momentum-2.95%
Direction and strength of recent price movements
Valuation-1.06%
How the stock is priced relative to its fundamentals
Sentiment-1.06%
How analysts and the market view the stock
Volatility-0.08%
How much the stock price tends to fluctuate

USPH probability advantage of beating the market (3M):

-4.67%

AI Score

Sell

US Physical Therapy (USPH) has an AI Score of 3/10 (Sell) because, according to an overall analysis, it has a probability advantage of -4.67% of beating the market (S&P500) in the next 3 months. This advantage is calculated as the difference between the average probability of any US-listed stock (50.82%) and the probability of USPH (46.14%) of outperforming the market in the next 3 months, as determined by Danelfin AI’s comprehensive analysis.

Average probability of any US-listed stock of beating the market (3M)50.82%
USPH probability advantage of beating the market (3M)-4.67%
USPH probability of beating the market (3M)46.14%

USPH probability advantage of beating the market (3M): -4.67%

The AI-powered overall analysis of US Physical Therapy (USPH) is based on the 27 fundamental, technical, and sentiment features that had the greatest impact on stock performance during the last 12 months (alpha signals). These alpha signals explain the probability advantage of USPH:

Type	Alpha Signal	Current Value	Value Decile Position	Probability Advantage Impact (3M)
Technical	Chart Pattern (252d)	figure_91	N/A	-0.84%
Sentiment	Sentiment Impact (Long Tail)	-	N/A	-0.78%
Technical	Distance from KAMA (20d)	0.09%		-0.68%
Sentiment	Fear & Greed Index (CNN)	31	N/A	-0.61%
Technical	ATR (14d Volatility)	2.5		-0.60%
Technical	Chart Pattern (180d)	figure_38	N/A	-0.60%
Technical	Alpha 1Y	-0.29%		+0.45%
Fundamental	Fundamentals Impact (Long Tail)	-	N/A	-0.42%
Sentiment	Short Float (%)	7.42%		-0.41%
Fundamental	Net Property, Plant & Equipment (Net PP&E)	38.62		-0.39%
Technical	Upgrade to unlock			-0.37%
Technical	Upgrade to unlock			+0.33%
Sentiment	Upgrade to unlock			+0.30%
Sentiment	Upgrade to unlock			+0.28%
Sentiment	Upgrade to unlock			-0.28%

Rest of Alpha Signals: +0.39%

USPH probability advantage of beating the market (3M)Total:-4.67%
USPH AI Score

Significant changes Vs previous day

USPH Short Trading Parameters

These suggested trading parameters for a 3-month horizon help improve risk management and decision-making.

Entry:$71.33
Horizon: 3 months
Stop Loss:$XXXXXPro (XXXXXPro)
Take Profit:$XXXXXPro (XXXXX
Pro
)

USPH Proven Sell Signal & Price Forecast

This is the price chart for USPH from January 1, 2026 until today. The chart indicates, in red, the 12 days when the stock received a Sell/Strong Sell rating (sell signals, AI Score 1 to 3).

Forecast: In the section below, the central dotted line represents the most expected path, while the shaded area indicates the anticipated price range. This is based on previous Sell signals with a 90% confidence level.

Full Track Record

Unlock AI-powered forecast

Closing price (USD)
Sell signals

Forecast:

1 Month
3 Months
6 Months
1 Year

USPH Average Past Performance & Loss Rate

Three months after its 359 Sell signals since July 2026, USPH had an average performance of xxxxxx and a xxxxxx Loss rate (negative performance).

359 Past USPH Sell Signals	1 Month Later	3 Months Later	6 Months Later	1 Year Later
Average Performance				+4.07%
Average Alpha				-12.49%
Loss Rate (% Negative Perf.)				42.96%
% Negative Alpha				69.63%

USPH Frequently Asked Questions

Will US Physical Therapy stock go up?
According to Danelfin AI, US Physical Therapy has today an AI Score of 3/10 (Sell rating), because its probability of beating the market in 3 months (46.14%) is -4.67% vs. the average probability (50.82%) of all US-listed stocks.
What is the target price for US Physical Therapy stock?
Is it a good time to buy, sell, or hold US Physical Therapy stock right now?
Is US Physical Therapy undervalued right now?
What was the price range of US Physical Therapy stock over the past 12 months?
What is going on with US Physical Therapy stock in the last 3 months?
Does US Physical Therapy offer dividend payments?
What is the current market capitalization of US Physical Therapy?
When is the next USPH earnings report date?

US Physical Therapy Inc Company Profile

U.S. Physical Therapy, Inc. is a provider of outpatient physical therapy services, operating via two main business divisions: Physical Therapy Operations and Industrial Injury Prevention Services. It caters to a range of needs including pre-and post-surgical care, treatment for injuries associated with orthopedic complications and sports activities, preventative maintenance care, rehabilitation services for workplace injuries, and therapeutic treatments for neurological impairments.

In addition to this core offering, U.S. Physical Therapy renders industrial injury prevention services. These are designed to help prevent workplace injuries and rehabilitate those injured on the job through the expertise of its dedicated team of physical therapists and professionally-trained athletic trainers. Their service offerings consist of onsite injury prevention as well as rehabilitation programs, performance enhancement initiatives, employment testing post-offer acceptance, functional capacity evaluations for determining work abilities, and ergonomic assessments.

These comprehensive solutions are made available to a diverse clientele spanning Fortune 500 companies to insurance agencies along with their contractors. U.S. Physical Therapy, Inc., established in 1990 has established its corporate headquarters in Houston, Texas from where it continues its operations.

Sector:
Country:United States
Industry:
Address:1300 West Sam Houston Parkway South, Suite 300, Houston
Employees:6,374
Website:usph.com

Pros

Aging population demographic tailwind for therapy demand

Growing preference for non-pharmacological pain management

Local physician referral network development

Fragmented market for acquisition-led growth

Patient adherence to established therapy protocols

Cons

Payer reimbursement rate pressure

Labor cost sensitivity for skilled therapists

Healthcare regulatory compliance burden

Reliance on external physician referral sources

Patient demand sensitivity to insurance plan changes

Pros

Cons

Company

AI Score

Compare

UHSUniversal Health Services Inc

ITOCiTonic Holdings Ltd

PACSPacs Group Inc

TOIOncology Institute Inc

UNHUnitedHealth Group Inc

Company

AI Score

Compare

USPH Top 10 Industry Stocks

Health Care Providers & Services

	Company	AI Score	Compare
1	ENSGEnsign Group Inc
2	BKDBrookdale Senior Living Inc
3	NHCNational Healthcare Corp
4	VMDViemed Healthcare Inc
5	ARDTArdent Health Inc
6	EHCEncompass Health Corp
7	HCAHCA Healthcare Inc
8	MCKMcKesson Corp
9	CICigna Group
10	NUTXNutex Health Inc

	Company	AI Score	Compare

	Company	AI Score	Compare
1	COGTCogent Biosciences Inc

Company

AI Score

Compare

COGTCogent Biosciences Inc

Company

AI Score

Compare

USPH Stock AI Analysis